These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32259886)

  • 1.
    Chen K; Lu Y; Peng F; Yu HL; Wu JY; Tan Y; Zhao YX
    J Integr Neurosci; 2020 Mar; 19(1):51-64. PubMed ID: 32259886
    [No Abstract]   [Full Text] [Related]  

  • 2. TGM6 might not be a specific causative gene for spinocerebellar ataxia resulting from genetic analysis and functional study.
    Cheng HL; Dong HL; Liu DS; Ni W; Ma Y; Yang L; Du YC; Chen DF; Dong Y; Wu ZY
    Gene; 2021 May; 779():145495. PubMed ID: 33588035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization.
    Guo YC; Lin JJ; Liao YC; Tsai PC; Lee YC; Soong BW
    Neurology; 2014 Oct; 83(17):1554-61. PubMed ID: 25253745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinocerebellar ataxia type 35 (SCA35)-associated transglutaminase 6 mutants sensitize cells to apoptosis.
    Guan WJ; Wang JL; Liu YT; Ma YT; Zhou Y; Jiang H; Shen L; Guo JF; Xia K; Li JD; Tang BS
    Biochem Biophys Res Commun; 2013 Jan; 430(2):780-6. PubMed ID: 23206699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing.
    Wang JL; Yang X; Xia K; Hu ZM; Weng L; Jin X; Jiang H; Zhang P; Shen L; Guo JF; Li N; Li YR; Lei LF; Zhou J; Du J; Zhou YF; Pan Q; Wang J; Wang J; Li RQ; Tang BS
    Brain; 2010 Dec; 133(Pt 12):3510-8. PubMed ID: 21106500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation.
    Manini A; Bocci T; Migazzi A; Monfrini E; Ronchi D; Franco G; De Rosa A; Sartucci F; Priori A; Corti S; Comi GP; Bresolin N; Basso M; Di Fonzo A
    BMC Neurol; 2020 Nov; 20(1):408. PubMed ID: 33160304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A significant inflation in TGM6 genetic risk casts doubt in its causation in spinocerebellar ataxia type 35.
    Fung JLF; Tsang MHY; Leung GKC; Yeung KS; Mak CCY; Fung CW; Chan SHS; Yu MHC; Chung BHY
    Parkinsonism Relat Disord; 2019 Jun; 63():42-45. PubMed ID: 30670339
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chen Y; Wu D; Luo B; Zhao G; Wang K
    Neurol Genet; 2020 Jun; 6(3):e424. PubMed ID: 32426513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hispanic Spinocerebellar Ataxia Type 35 (SCA35) with a Novel Frameshift Mutation.
    Lin CC; Gan SR; Gupta D; Alaedini A; Green PH; Kuo SH
    Cerebellum; 2019 Apr; 18(2):291-294. PubMed ID: 30229425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing identifies a novel mutation in the transglutaminase 6 gene for spinocerebellar ataxia in a Chinese family.
    Li M; Pang SY; Song Y; Kung MH; Ho SL; Sham PC
    Clin Genet; 2013 Mar; 83(3):269-73. PubMed ID: 22554020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
    Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA
    Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.
    Verhaar R; Jongenelen CA; Gerard M; Baekelandt V; Van Dam AM; Wilhelmus MM; Drukarch B
    Neurochem Int; 2011 Jun; 58(7):785-93. PubMed ID: 21440023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein.
    Martinez JH; Alaimo A; Gorojod RM; Porte Alcon S; Fuentes F; Coluccio Leskow F; Kotler ML
    Mol Cell Neurosci; 2018 Apr; 88():107-117. PubMed ID: 29414102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
    Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu Y; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ
    Brain; 2019 Sep; 142(9):2845-2859. PubMed ID: 31312839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
    Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
    Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of small ubiquitin-like modifier-1 modification on the formation of Lewy body-like inclusions in cytoplasm and apoptosis of HEK293 cell induced by overexpression and mutation of alpha-synuclein].
    Chen T; Liao XP; Wen GQ; Long ZG; Ouyang F; Deng YD; Guo M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Oct; 28(5):511-6. PubMed ID: 21983723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
    Choong CJ; Say YH
    Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.